For the latest COVID-19 (Coronavirus) information: CCTG public updates | CCTG member information

CCTG SC24 practice changing trial results presented at the ASTRO 2020 meeting

Treating spinal lesions with fewer, higher doses of radiation reduces pain more effectively
Wednesday, November 4, 2020
Lead author Dr. Arjun Sahgal, deputy chief of radiation oncology at the Sunnybrook Health Sciences Centre of the University of Toronto, presented the findings from the CCTG SC24 at the American Society for Radiation Oncology (ASTRO) Annual Meeting last week. This randomized phase II/III trial is the first to show that stereotactic body radiation therapy is superior to conventional radiation treatments in alleviating pain from spinal metastases.
 

The results indicate that using fewer and higher doses of high-precision radiation therapy is a more effective approach for treating painful spinal tumors than conventional radiation therapy. More than twice as many patients treated with stereotactic body radiation therapy (SBRT) reported an enduring, complete reduction in pain, compared to those treated with conventional radiation.

For more about the presentation.